Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.005
+0.055 (2.82%)
Oct 8, 2025, 1:38 PM EDT - Market open
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $190.59 million as of October 8, 2025. Its market cap has increased by 4.92% in one year.
Market Cap
190.59M
Enterprise Value
152.25M
1-Year Change
4.92%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $190.59M, an increase of 52.21%. That is a compound annual growth rate of 3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 186.12M | 12.40% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | 334.40M | -36.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |